1. Home
  2. RVSB vs DBVT Comparison

RVSB vs DBVT Comparison

Compare RVSB & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVSB
  • DBVT
  • Stock Information
  • Founded
  • RVSB 1923
  • DBVT 2002
  • Country
  • RVSB United States
  • DBVT France
  • Employees
  • RVSB N/A
  • DBVT N/A
  • Industry
  • RVSB Savings Institutions
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RVSB Finance
  • DBVT Health Care
  • Exchange
  • RVSB Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • RVSB 122.2M
  • DBVT 102.0M
  • IPO Year
  • RVSB 1993
  • DBVT N/A
  • Fundamental
  • Price
  • RVSB $5.14
  • DBVT $4.40
  • Analyst Decision
  • RVSB
  • DBVT Strong Buy
  • Analyst Count
  • RVSB 0
  • DBVT 2
  • Target Price
  • RVSB N/A
  • DBVT $22.50
  • AVG Volume (30 Days)
  • RVSB 34.8K
  • DBVT 28.0K
  • Earning Date
  • RVSB 01-30-2025
  • DBVT 03-06-2025
  • Dividend Yield
  • RVSB 1.54%
  • DBVT N/A
  • EPS Growth
  • RVSB N/A
  • DBVT N/A
  • EPS
  • RVSB 0.04
  • DBVT N/A
  • Revenue
  • RVSB $46,646,000.00
  • DBVT $12,515,000.00
  • Revenue This Year
  • RVSB N/A
  • DBVT N/A
  • Revenue Next Year
  • RVSB $13.88
  • DBVT $2,860.00
  • P/E Ratio
  • RVSB $139.08
  • DBVT N/A
  • Revenue Growth
  • RVSB N/A
  • DBVT 125.54
  • 52 Week Low
  • RVSB $3.30
  • DBVT $0.44
  • 52 Week High
  • RVSB $5.89
  • DBVT $5.42
  • Technical
  • Relative Strength Index (RSI)
  • RVSB 20.43
  • DBVT 54.39
  • Support Level
  • RVSB $5.30
  • DBVT $4.18
  • Resistance Level
  • RVSB $5.48
  • DBVT $4.47
  • Average True Range (ATR)
  • RVSB 0.10
  • DBVT 0.28
  • MACD
  • RVSB -0.04
  • DBVT -0.04
  • Stochastic Oscillator
  • RVSB 0.00
  • DBVT 71.34

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

Share on Social Networks: